期刊文献+

肿瘤浸润淋巴细胞与胃癌预后关系的研究进展 被引量:10

Research Progress of the Relationship Between Tumor Infiltrating Lymphocytes and Gastric Carcinoma
下载PDF
导出
摘要 胃癌是全球最常见的恶性肿瘤之一,影响胃癌预后的因素较多,患者的肿瘤局部免疫反应就是其中之一。近年来肿瘤浸润淋巴细胞成为胃癌预后的热点研究。本文介绍了胃癌肿瘤浸润淋巴细胞的亚型、临床分型及与患者预后关系的研究进展,认为胃癌内的调节性T细胞(Treg)通常与不利的预后相关,而肿瘤浸润的CD8+细胞毒性T细胞、CD45RO记忆T细胞、B淋巴细胞和淋巴小结通常与良好的胃癌预后相关,为进一步研究胃癌患者肿瘤局部免疫反应的关键机制和临床治疗提供了一定依据。 Gastric cancer is one of the most common malignant tumors in the world. The influencing factors for gastric carcinoma are numerous,among which tumor local immune response is one of the influencing factors. In recent years,tumor infiltrating lymphocytes became a hot issue in the research of gastric cancer prognosis. In this paper,we introduced the subtypes and clinical classification of tumor infiltrating lymphocytes of gastric cancer. And we found that Treg in gastric carcinoma is normally associated with unfavorable prognosis,and tumor- infiltrating CD8+CTLs,CD45 RO memory T cells,B lymphocyte and lymph nodules are normally associated with favorable prognosis of gastric carcinoma. The findings may provide a reference for the further research of the key mechanism of tumor local immune response in patients with gastric cancer and clinical treatment.
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第28期3496-3500,共5页 Chinese General Practice
基金 国家自然科学基金资助项目(81201763) 湛江市科技攻关项目(2011C3108011)
关键词 胃肿瘤 淋巴细胞 肿瘤浸润 预后 Stomach neoplasms Lymphocytes tumor-infiltrating Prognosis
  • 相关文献

参考文献38

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011, 61 (2): 69-90. 被引量:1
  • 2Coombes RC, Schein PS, Chilvers CE, et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group [J]. JClinOncol, 1990, 8 (8): 1362 - 1369. 被引量:1
  • 3Bang Y J, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC) : a phase 3 open - label, randomized controlled trial [ J ]. Lancet, 2012, 379 (9813): 315-321. 被引量:1
  • 4Sasako M, Sakuramoto S, Katai H, et al. Five - year outcomes of a randomized phase m trial comparing adjuvant chemotherapy with S - 1 versus surgery alone in stage Ⅱ or Ⅲ gastric cancer [ J ]. J Clin Oncol,2011, 29 (33): 4387-4393. 被引量:1
  • 5Yannelli JR, Hyatt C, MeConnell S, et al. Growth of tumor - infiltrating lymphoeytes from human solid cancers : summary of a 5 - year experience [ J]. Int J Cancer, 1996, 65 (4) : 413 -421. 被引量:1
  • 6Sistrunk WE, Maccarty WC. Life expectancy following radical amputation for carcinoma of the breast: a clincal and pathologic study of 218 cases [ J ]. Ann Surg, 1922, 75 (1) : 61 -69. 被引量:1
  • 7Chen LJ, Zheng X, Shen YP, et al. Higher numbers of T-bet ( + ) intratumoral lymphoid cells correlate with better survival in gastric cancer [ J ]. Cancer Immunol Immunother, 2013, 62 (3): 553-561. 被引量:1
  • 8Smyth M J, Swann J, Hayakawa Y. Innate tumor immune surveillance [ J ]. Adv Exp Med Biol, 2007, 590:103 - 111. 被引量:1
  • 9Dong J, LiJ, Liu SM, etal. CD33 +/p- STAT1 + double - positive cell as a prognostic factor for stage Ⅲ a gastric cancer [J]. MedOncol, 2013, 30 (1): 442. 被引量:1
  • 10Johansson M, Denardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development [J ]. Immunol Rev, 2008, 222:145 - 154. 被引量:1

同被引文献99

引证文献10

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部